ACT-1004-1239

Overview

ACT-1004-1239 is a potent, selective, orally active CXCR7 antagonist with an IC 50 value of 3.2 nM.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > CXCR

Product Information

• Catalog No.: HY-142617
• CAS No.: 2178049-58-4
• Molecular Formula: C27H28F2N6O3
• Molecular Weight: 522.55
• Purity: 98.81%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 1.67 mg/mL (3.20 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source